When evidence doesn't generalise: the case of ACE inhibition
Access status:
Open Access
Type
ArticleDate
2015-10-22Publisher
ElsevierLicence
OtherRights statement
This is a pre-copyedited, author-produced version of an article accepted for publication in Lancet Diabetes and Endocrinology following peer review. The version of record [Webster AC, Cross NB. When evidence doesn't generalise: the case of ACE-inhibition. The Lancet Diabetes & Endocrinology, 2016; 4(4): 290-2] is available online at: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00415-5/fulltext [https://doi.org/10.1016/S2213-8587(15)00415-5].Faculty/School
Faculty of Medicine and Health, Sydney Medical SchoolCitation
Webster AC, Cross NB. When evidence doesn't generalise: the case of ACE-inhibition. The Lancet Diabetes & Endocrinology, 2016; 4(4): 290-2Share